Special situation from BSE disclosures
Bacil Pharma Ltd · BSE 524516 · market cap ≈ ₹55 Cr at last filing

Large non-promoter block reshuffling, coordinated independent director exits, and a ₹50 Cr rights issue raise governance and dilution questions for minority shareholders

Tracking since 2025-07-22 · 15 filings analysed · last filing 2026-07-10 · analysis updated 2026-07-16
AccumulationPromoter transitionCapital infusion · detected 2026-07-16Accumulation · detected 2026-09-09
Structural change first flagged 2026-02-23 · stock -45% since
Who's involved: Suman Shah · Prashant Natwarlal Lakhani · Chaitali Kalpataru Shah · Ankitkumar Surendrakumar Agrawal · Avani Savjibhai Godhaniya · Dinesh Chander Notiyal — full analysis of all actors on the Bench →
Closing price since 2026-02-23
Daily closes, adjusted for splits and bonuses · 2026-02-23 → 2026-10-05 · ₹49.6 → ₹27.3
Read the full situation analysis — who's involved, where the facts lean, what happened next
The full analysis names the people and entities involved with their documented history, shows where the filed facts lean for minority shareholders, and keeps tracking the situation as new filings arrive.
Filing timeline (from BSE disclosures)
2026-07-10Fundraising
2026-07-09Fundraising
2026-06-29Board change
2026-06-29New significant shareholder
2026-06-25Significant shareholder — stake change
2026-06-24Significant shareholder — stake change
2026-06-13Significant shareholder — stake change
2026-06-11Significant shareholder — stake change
Common questions (from the filings record)
What special situation is unfolding at Bacil Pharma Ltd?
Large non-promoter block reshuffling, coordinated independent director exits, and a ₹50 Cr rights issue raise governance and dilution questions for minority shareholders. Based on 15 BSE filings analysed; last filing 2026-07-10.
Who is involved at Bacil Pharma Ltd?
People named in the analysed filings include Suman Shah, Prashant Natwarlal Lakhani, Chaitali Kalpataru Shah, Ankitkumar Surendrakumar Agrawal, Avani Savjibhai Godhaniya and Dinesh Chander Notiyal.
When did Special Situations Bench first flag Bacil Pharma Ltd?
Special Situations Bench first flagged structural change on 2026-02-23. The stock has moved -45% since, adjusted for splits and bonuses. Winners and losers are shown alike — this is not a recommendation.
What patterns have been detected at Bacil Pharma Ltd?
Detected patterns: Capital infusion (2026-07-16); Accumulation (2026-09-09).
What flagged situations did next — a young track record
68%
of 72 flagged situations whose first 90 days completed were higher after the triggering filing
+10.3%
median 90-day move (mean +36.6%)
1 in 14 >2×
of 1,138 situations in a 2023–25 hindsight scan at least doubled within a year
Observational record, not performance of any portfolio. Live figures from 1 March 2026, measured as of 9 September 2026; the one-year set was identified in hindsight and is labelled as such. Moves are closing-price changes adjusted for splits and bonuses. Past movement does not indicate future movement.
What the Special Situations Bench is
The Bench scans every BSE corporate disclosure daily for event-driven special situations in Indian small- and micro-cap stocks — preferential allotments, open offers, changes of control, reverse mergers, accumulation by notable investors, debt settlements, capacity expansion and more.
Situations are flagged as the filings cluster — before they become stories — and every flagged situation is tracked against what the stock did next, winners and losers alike.
The full analysis connects the dots: what the filings add up to, the people and companies involved — with their documented history and a connections graph of how they link across other listed companies — and where the facts lean for minority shareholders.
About the Special Situations Bench →
Other situations with similar patterns
Special Situations Bench a Humdinger HQ product
situations.humdingerhq.ai is not a SEBI-registered research analyst. Nothing here is investment advice or a recommendation. Observations are drawn from public exchange disclosures.